MX2022002532A - Métodos para generar y aislar neuronas de dopamina del mesencéfalo. - Google Patents
Métodos para generar y aislar neuronas de dopamina del mesencéfalo.Info
- Publication number
- MX2022002532A MX2022002532A MX2022002532A MX2022002532A MX2022002532A MX 2022002532 A MX2022002532 A MX 2022002532A MX 2022002532 A MX2022002532 A MX 2022002532A MX 2022002532 A MX2022002532 A MX 2022002532A MX 2022002532 A MX2022002532 A MX 2022002532A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- isolating
- generating
- dopamine neurons
- midbrain dopamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Ophthalmology & Optometry (AREA)
- Gynecology & Obstetrics (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962893674P | 2019-08-29 | 2019-08-29 | |
| PCT/US2020/048733 WO2021042027A1 (en) | 2019-08-29 | 2020-08-31 | Methods of generating and isolating midbrain dopamine neurons |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022002532A true MX2022002532A (es) | 2022-06-16 |
Family
ID=74686069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022002532A MX2022002532A (es) | 2019-08-29 | 2020-08-31 | Métodos para generar y aislar neuronas de dopamina del mesencéfalo. |
Country Status (13)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2960527T3 (es) | 2019-09-13 | 2024-03-05 | Miltenyi Biotec Bv & Co Kg | Método para la generación de una composición celular de células progenitoras dopaminérgicas del mesencéfalo ventral |
| EP4314256A1 (en) | 2021-03-30 | 2024-02-07 | Trailhead Biosystems Inc. | Methods and compositions for generating oligodendrocyte progenitor cells |
| JP2024523738A (ja) | 2021-07-14 | 2024-06-28 | ノヴォ ノルディスク アー/エス | ニューロンおよびその前駆体が富化された細胞集団を提供するための方法 |
| CN115354028B (zh) * | 2021-10-28 | 2023-05-23 | 中国科学院动物研究所 | 一种中脑多巴胺细胞群、其制造方法以及用途 |
| KR20250040032A (ko) * | 2022-07-21 | 2025-03-21 | 트레일헤드 바이오시스템즈 인크. | 신경 전구체 세포로부터 인간 중뇌 도파민성 뉴런을 생성시키기 위한 방법 및 조성물 |
| WO2024259119A2 (en) | 2023-06-13 | 2024-12-19 | Aspen Neuroscience, Inc. | Methods for differentiating dopaminergic neurons from stem cells |
| AU2025217196A1 (en) | 2024-01-31 | 2026-07-09 | Bluerock Therapeutics Lp | Igfbp2 in cell culture |
| CN117838835B (zh) * | 2024-02-01 | 2024-11-08 | 暨南大学 | 成纤维细胞生长因子17蛋白和/或其激活剂在制备治疗阿尔兹海默病药物中的应用 |
| WO2025252180A1 (zh) * | 2024-06-05 | 2025-12-11 | 中国科学院脑科学与智能技术卓越创新中心 | 中脑多巴胺能祖细胞群的体外制备方法 |
| WO2026039433A1 (en) * | 2024-08-12 | 2026-02-19 | Memorial Sloan-Kettering Cancer Center | Midbrain dopaminergic neuron compositions and methods of use |
| WO2026096366A1 (en) | 2024-10-28 | 2026-05-07 | Bluerock Therapeutics Lp | Compositions and methods for determination of pluripotent stem cell differentiability |
| CN119776284B (zh) * | 2025-03-13 | 2025-06-20 | 首都医科大学宣武医院 | 含有多巴胺能荧光报告系统的细胞及异步共培养方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7632679B2 (en) * | 2002-07-16 | 2009-12-15 | The Trustees Of Columbia University In The City Of New York | Systems and methods for screening for modulators of neural differentiation |
| US8642334B2 (en) * | 2009-02-17 | 2014-02-04 | Memorial Sloan Kettering Cancer Center | Methods of neural conversion of human embryonic stem cells |
| WO2013015457A1 (en) * | 2011-07-27 | 2013-01-31 | Kyoto University | Novel markers for dopaminergic neuron progenitor cells |
| AU2012332269B2 (en) * | 2011-11-04 | 2018-05-31 | Memorial Sloan-Kettering Cancer Center | Midbrain dopamine (DA) neurons for engraftment |
| EP2614829A1 (en) * | 2012-01-11 | 2013-07-17 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Mammalian neural plate border stem cells capable of forming neural tube and neural crest cell lineages including central and peripheral neurons |
| CN121136933A (zh) * | 2013-09-05 | 2025-12-16 | 国立大学法人京都大学 | 由多能干细胞制造产多巴胺神经前体细胞的方法、产多巴胺神经前体细胞、帕金森病治疗剂和试剂盒 |
| EP3280426B1 (en) * | 2015-04-09 | 2025-06-25 | Biolamina AB | Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases |
| WO2016196661A1 (en) * | 2015-06-01 | 2016-12-08 | Memorial Sloan-Kettering Cancer Center | Methods of in vitro differentiation of midbrain dopamine (mda) neurons |
| AU2017313065B2 (en) * | 2016-08-16 | 2021-06-24 | Fujifilm Cellular Dynamics Inc. | Methods for differentiating pluripotent cells |
-
2020
- 2020-08-31 KR KR1020227010271A patent/KR20220051388A/ko active Pending
- 2020-08-31 CN CN202080075663.3A patent/CN114650836B/zh active Active
- 2020-08-31 EP EP20856169.6A patent/EP4021477A4/en active Pending
- 2020-08-31 PH PH1/2022/550496A patent/PH12022550496A1/en unknown
- 2020-08-31 BR BR112022003826A patent/BR112022003826A2/pt unknown
- 2020-08-31 CA CA3152522A patent/CA3152522A1/en active Pending
- 2020-08-31 AU AU2020336221A patent/AU2020336221A1/en active Pending
- 2020-08-31 JP JP2022513499A patent/JP7759870B2/ja active Active
- 2020-08-31 MX MX2022002532A patent/MX2022002532A/es unknown
- 2020-08-31 CN CN202511379930.7A patent/CN121227633A/zh active Pending
- 2020-08-31 WO PCT/US2020/048733 patent/WO2021042027A1/en not_active Ceased
-
2022
- 2022-02-25 US US17/681,113 patent/US20220177835A1/en active Pending
- 2022-02-27 IL IL290930A patent/IL290930A/en unknown
- 2022-03-11 ZA ZA2022/02994A patent/ZA202202994B/en unknown
-
2025
- 2025-10-14 JP JP2025172808A patent/JP2026001236A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021042027A1 (en) | 2021-03-04 |
| CN121227633A (zh) | 2025-12-30 |
| US20220177835A1 (en) | 2022-06-09 |
| PH12022550496A1 (en) | 2023-03-20 |
| CN114650836A (zh) | 2022-06-21 |
| EP4021477A1 (en) | 2022-07-06 |
| CN114650836B (zh) | 2025-10-17 |
| BR112022003826A2 (pt) | 2022-05-31 |
| JP7759870B2 (ja) | 2025-10-24 |
| JP2022546482A (ja) | 2022-11-04 |
| AU2020336221A1 (en) | 2022-04-07 |
| EP4021477A4 (en) | 2023-12-13 |
| JP2026001236A (ja) | 2026-01-06 |
| CA3152522A1 (en) | 2021-03-04 |
| IL290930A (en) | 2022-04-01 |
| ZA202202994B (en) | 2022-12-21 |
| KR20220051388A (ko) | 2022-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022002759A2 (es) | Antagonistas de hpk1 y sus usos | |
| ECSP21086429A (es) | Moduladores de la vía integrada del estrés | |
| PH12022550496A1 (en) | Methods of generating and isolating midbrain dopamine neurons | |
| CO2021006098A2 (es) | Moduladores de profármacos de la vía de estrés integrada | |
| MX2020001103A (es) | Inhibidores de tirosina cinasa 2 (tyk2) y usos de los mismos. | |
| CL2024001411A1 (es) | Inhibidores de molécula pequeña de proteasa específica de ubiquitina 1 (usp1) y sus usos | |
| CO2023010023A2 (es) | Inhibidores de cdk2 y métodos de uso de los mismos | |
| CL2020002573A1 (es) | Inhibidores atf6 y sus usos. | |
| CR20190150A (es) | Formulaciones de anticuerpos inhibidores de masp-2 altamente concentrados, de baja viscosidad, kits, y métodos | |
| UY38685A (es) | Moduladores de la vía de tensión integrada | |
| MX392605B (es) | Compuestos, composiciones y metodos para el tratamiento de enfermedades. | |
| MX2020003594A (es) | Inhibidores de la quinasa p38 que reducen la expresión de dux4 y de los genes corriente abajo para el tratamiento de fshd. | |
| MX2020004534A (es) | Moduladores de la vía integrada del estrés. | |
| DOP2020000252A (es) | Inhibidores de proteina tirosina fosfatasa y sus métodos de uso | |
| MX2023011933A (es) | Moduladores del linfoma de linaje b de casitas de ligasa e3 b (cbl-b) y usos de estos. | |
| NI202100018A (es) | Moduladores de la expresión de pnpla3 | |
| MX2022012366A (es) | Metodos para generar neuronas de dopamina del mesencefalo, neuronas del mesencefalo, y usos de las mismas. | |
| MX387359B (es) | Inhibidores de cinasa activada por mitógeno 2 (mk2), síntesis de los mismos, e intermediarios de los mismos. | |
| MX2022006817A (es) | Formulaciones/composiciones que comprenden un inhibidor de btk. | |
| MX2022009762A (es) | Moduladores del purinorreceptor 3 p2x (p2x3). | |
| CL2024001566A1 (es) | Moduladores de la vía integrada del estrés | |
| CO2021007006A2 (es) | Moduladores de la expresión de irf5 | |
| MX2022006163A (es) | Nuevas composiciones de barrera protectora y usos de las mismas. | |
| CL2021000930A1 (es) | Piridazinas novedosas | |
| MX2021009423A (es) | Formas cristalinas de un inhibidor de la janocinasa 2 (jak2). |